Myriad Genetics, Inc.
Built from real-time financials and updated daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a MYGN research report →
Companymyriad.com
Myriad Genetics, Inc. , a genetic testing and precision medicine company, develops and commercializes genetic tests in the United States and internationally. The company offers molecular diagnostic tests for use in oncology, and women's and mental health applications.
- CEO
- Samraat S. Raha
- IPO
- 1995
- Employees
- 2,700
- HQ
- Salt Lake City, UT, US
Price Chart
Valuation
- Market Cap
- $349.93M
- P/E
- -0.87
- P/S
- 0.42
- P/B
- 1.03
- EV/EBITDA
- -1.31
- Div Yield
- 0.00%
Profitability
- Gross Margin
- 69.96%
- Op Margin
- -46.26%
- Net Margin
- -48.24%
- ROE
- -109.09%
- ROIC
- -69.65%
Growth & Income
- Revenue
- $824.50M · -1.56%
- Net Income
- $-365,900,000 · -187.43%
- EPS
- $-3.96 · -180.85%
- Op Income
- $-67,800,000
- FCF YoY
- 64.06%
Performance & Tape
- 52W High
- $8.59
- 52W Low
- $3.53
- 50D MA
- $4.59
- 200D MA
- $6.02
- Beta
- 1.64
- Avg Volume
- 1.97M
Get TickerSpark's AI analysis on MYGN
Pro members can request AI-generated analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →30-day money-back guarantee · cancel anytime
Recent Insider Transactions
| Date | Insider | Type | Shares |
|---|---|---|---|
| May 14, 26 | Bisaro Paul | buy | 7,500 |
| May 1, 26 | Donnelly Brian J | other | 55,975 |
| Apr 14, 26 | Verratti Mark | other | 1,069 |
| Apr 14, 26 | Muzzey Dale | other | 946 |
| Mar 22, 26 | Muzzey Dale | other | 2,019 |
| Mar 22, 26 | Verratti Mark | other | 2,055 |
| Mar 22, 26 | Wheeler Benjamin Richard | other | 549 |
| Mar 13, 26 | Haas Kevin Richard | other | 6,412 |
| Mar 14, 26 | Haas Kevin Richard | other | 4,161 |
| Mar 15, 26 | Haas Kevin Richard | other | 3,355 |
Our MYGN Coverage
We haven't published any research on MYGN yet
For a full analyst-grade research report — grades, price targets, full financials, chart analysis — generate one on demand.
Generate MYGN Report →